Content Type: Research Publications

What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?

March 15, 2026

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved By the FDA, 2013-2016

March 15, 2026

Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018

March 15, 2026

The Swinging Pendulum: The Supreme Court Reverses Course on ERISA and Managed Care

March 15, 2026

Changing FDA Approval Standards: Ethical Implications for Patient Consent

March 15, 2026

Medical-Process Patents—Monopolizing the Delivery of Health Care

March 15, 2026

Public-Sector Contributions to Novel Biologic Drugs

March 15, 2026

Scientific and Legal Viability of Follow-On Protein Drugs

March 15, 2026

Medicare Spending on Drugs with Accelerated Approval, 2015-2019

March 15, 2026

Expert Review of Drug Patent Applications: Improving Health in the Developing World

March 15, 2026

Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals

March 15, 2026

Improving Antibiotic Markets for Long-Term Sustainability

March 15, 2026